CoChat

Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation

Open access
Lam, Chu-Shing, Xia, Yi-Xuan, Chen, Bai-Sen, Du, Yin-Xiao, Liu, Kang-Lun, Zhang, Hong-Jie · 2023 · Nutrients

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Management of obesity has become a prevalent strategy for preventing the diseases closely integrated with excess body weight such as diabetes over the last half century. Searching for therapeutic agents acting on oxidative stress, adipogenesis and insulin resistance is considered as an efficient approach to control obesity-related diseases. The present study was designed to examine the in vitro and in vivo effects of dihydro-resveratrol (DR2), a naturally occurring compound from Dendrobium medicinal plants, on oxidative stress aggravation, adipogenesis, lipogenesis and insulin sensitivity. We utilized an in vitro 3T3-L1 adipocyte differentiation model to show that DR2 could reduce pre-adipocyte maturation by activation of AMPK/SIRT1 signaling proteins to inhibit p38MAPK proteins. With the use of in vitro oxidative-stress-induced hepatocytes and myoblasts models, DR2 was also shown to be able to reduce oxidative stress aggravation through mediation of Nrf2-related antioxidative cascade, reduce intracellular lipid accumulation through phosphorylation of ACC protein, reduce lipid peroxidation in hepatocytes and promote insulin sensitivity via activation of AKT protein in the insulin-resistant HepG2 cells and C2C12 cells. The effects of DR2 on adipogenesis, lipid accumulation, insulin resistance and blood glucose clearance were further demonstrated in the high-fat diet-induced obesity mouse model. Our in vitro and in vivo studies determined that DR2 could contain therapeutic potential for the treatment of obesity and type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15133006

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of DR2 on adipocyte differentiation of 3T3–L1 cells. (A) Structures of dihydro–resveratrol (DR2) and resveratrol (RES). (B) The Oil Red O staining images and (C) quantifications of MDIR–stimulated 3T3–L1 cells with or without DR2/RES treatment. Scale bar = 100 μm. (D) Western blot results and (E) quantifications that indicated that DR2 reduced adipogenesis and lipogenesis markers in 3T3–L1 cells. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. CON group; ## p < 0.01 vs. MDIR group.
Figure 1 Effect of DR2 on adipocyte differentiation of 3T3–L1 cells. (A) Structures of dihydro–resveratrol (DR2) and resveratrol (RES). (B) The Oil Red O staining images and (C) quantifications of MDIR–stimulated 3T3–L1 cells with or without DR2/RES treatment. Scale bar = 100 μm. (D) Western blot results and (E) quantifications that indicated that DR2 reduced adipogenesis and lipogenesis markers in 3T3–L1 cells. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. CON group; ## p < 0.01 vs. MDIR group.CC BY · PubMed Central
Figure 2 Modulation of cell signaling proteins of DR2 on adipocyte differentiation of 3T3-L1 cells. (A) Western blot images and (B) quantifications indicated that DR2 reduced adipogenesis and lipogenesis via modulation of AMPK/SIRT1 signaling and phosphorylation of p38αβ in 3T3–L1 cells. ** p < 0.01 and *** p < 0.001 vs. CON group; ## p < 0.01 and ### p < 0.001 vs. MDIR group.
Figure 2 Modulation of cell signaling proteins of DR2 on adipocyte differentiation of 3T3-L1 cells. (A) Western blot images and (B) quantifications indicated that DR2 reduced adipogenesis and lipogenesis via modulation of AMPK/SIRT1 signaling and phosphorylation of p38αβ in 3T3–L1 cells. ** p < 0.01 and *** p < 0.001 vs. CON group; ## p < 0.01 and ### p < 0.001 vs. MDIR group.CC BY · PubMed Central
Figure 3 Effects of DR2 on oxidative stress markers in HepG2 cells. Western blot results and quantifications that indicated that DR2 reduced oxidative stress markers via phosphorylation of AMPKα in (A,B) H2O2–induced HepG2 cells and (C–G) high–glucose high–insulin–exposed HepG2 cells. (E) MDA levels after DR2 treatment in high glucose high insulin exposed HepG2 cells. * p < 0.05 and ** p < 0.01 vs. CON group; # p < 0.05 vs. H2O2 group.
Figure 3 Effects of DR2 on oxidative stress markers in HepG2 cells. Western blot results and quantifications that indicated that DR2 reduced oxidative stress markers via phosphorylation of AMPKα in (A,B) H2O2–induced HepG2 cells and (C–G) high–glucose high–insulin–exposed HepG2 cells. (E) MDA levels after DR2 treatment in high glucose high insulin exposed HepG2 cells. * p < 0.05 and ** p < 0.01 vs. CON group; # p < 0.05 vs. H2O2 group.CC BY · PubMed Central
Figure 4 Effect of DR2 treatment on oleic acid–stimulated HepG2 cells. (A) The Oil Red O staining images and (B) quantifications of oleic acid–stimulated HepG2 cells with or without DR2 treatments (62.5 µM to 500 µM). Scale bar = 100 μm. (C–E) Western blot results and (F–H) quantifications that indicated that DR2 is an in vitro ACC inhibitor via modulation of ACC/AMPK signaling in HepG2 cells. * p < 0.05, ** p < 0.01 and *** p < 0.01 vs. CON group; # p < 0.05 and ### p < 0.001 vs. OA group.
Figure 4 Effect of DR2 treatment on oleic acid–stimulated HepG2 cells. (A) The Oil Red O staining images and (B) quantifications of oleic acid–stimulated HepG2 cells with or without DR2 treatments (62.5 µM to 500 µM). Scale bar = 100 μm. (C–E) Western blot results and (F–H) quantifications that indicated that DR2 is an in vitro ACC inhibitor via modulation of ACC/AMPK signaling in HepG2 cells. * p < 0.05, ** p < 0.01 and *** p < 0.01 vs. CON group; # p < 0.05 and ### p < 0.001 vs. OA group.CC BY · PubMed Central
Figure 5 Effect of DR2 on insulin sensitivity of HGHI–exposed cell models. Western blot results that indicated that DR2 increased insulin sensitivity of insulin-resistant (A,B) HepG2 cells and (C,D) C2C12 cells via upregulations of phosphorylated AKT protein expression levels. Statistical significance considered as * p < 0.05, ** p < 0.01, *** p < 0.001 and n.s as no significance.
Figure 5 Effect of DR2 on insulin sensitivity of HGHI–exposed cell models. Western blot results that indicated that DR2 increased insulin sensitivity of insulin-resistant (A,B) HepG2 cells and (C,D) C2C12 cells via upregulations of phosphorylated AKT protein expression levels. Statistical significance considered as * p < 0.05, ** p < 0.01, *** p < 0.001 and n.s as no significance.CC BY · PubMed Central
Figure 6 Effects of DR2 treatment on body weights and blood glucose clearance of HFD-treated C57/BL6 mice. (A) DR2 treatment period indication in high–fat–diet–fed mouse model. (B) Body weights of the experimental groups over the periods, percentage change of weights after DR2 or vehicle solution treatment and daily food intake between the high–fat–diet groups during treatment. (C) Intraperitoneal glucose tolerance test after 3 weeks of DR2 treatment. (D) qPCR analysis of liver Gck transcripts after 3 weeks of DR2 treatments. (E) qPCR analysis of iWAT Mcp1 transcripts after 3 weeks of DR2 treatments. N = 6–8 (F) Western blot result of hepatic p–AMPK and AMPK protein expression level after 3 weeks of DR2 treatments. N = 4 * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. CON group; # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. HFD group; n.s as no significance.
Figure 6 Effects of DR2 treatment on body weights and blood glucose clearance of HFD-treated C57/BL6 mice. (A) DR2 treatment period indication in high–fat–diet–fed mouse model. (B) Body weights of the experimental groups over the periods, percentage change of weights after DR2 or vehicle solution treatment and daily food intake between the high–fat–diet groups during treatment. (C) Intraperitoneal glucose tolerance test after 3 weeks of DR2 treatment. (D) qPCR analysis of liver Gck transcripts after 3 weeks of DR2 treatments. (E) qPCR analysis of iWAT Mcp1 transcripts after 3 weeks of DR2 treatments. N = 6–8 (F) Western blot result of hepatic p–AMPK and AMPK protein expression level after 3 weeks of DR2 treatments. N = 4 * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. CON group; # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. HFD group; n.s as no significance.CC BY · PubMed Central
Figure 7 Effects of DR2 treatment on lipid aggregation and adipogenesis of HFD-treated C57/BL6 mice. (A) Hepatic Oil Red O staining images with (B) quantifications (200×). Scale bar = 100 μm. (C) H&E staining images and (D) quantification of iWAT tissues (400×). Scale bar = 50 μm. N = 6–8. Statistical significance considered as ** p < 0.01 and *** p < 0.001.
Figure 7 Effects of DR2 treatment on lipid aggregation and adipogenesis of HFD-treated C57/BL6 mice. (A) Hepatic Oil Red O staining images with (B) quantifications (200×). Scale bar = 100 μm. (C) H&E staining images and (D) quantification of iWAT tissues (400×). Scale bar = 50 μm. N = 6–8. Statistical significance considered as ** p < 0.01 and *** p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 49 references

Cited by

See all 29

Metadata

Authors
Lam, C.-S., Xia, Y.-X., Chen, B.-S., Du, Y.-X., Liu, K.-L., & Zhang, H.-J.
Affiliations
  • Hong Kong Baptist University (HK)
  • Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China
Venue
Nutrients
Publisher
MDPI AG
Published
2023-06-30
Volume
15
Issue
13
Pages
3006
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4382936765
Cited by
28
References
49
Citations by year
2026: 9 · 2025: 10 · 2024: 7 · 2023: 2
FWCI
4.18
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Research Grants Council of the Hong Kong Special Administrative Region, China (HKBU12101718, COVID190214)
  • Government of the Hong Kong Special Administrative Region (HKBU12101718, COVID190214)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
Dendrobium, oxidative stress, adipogenesis, insulin resistance, AMPK, SIRT1, p38 MAPK, Nrf2, lipid peroxidation, lipid accumulation, Akt, type 2 diabetes, obesity, high-fat diet, 3T3-L1 adipocytes, HepG2 cells, C2C12 myoblasts
MeSH terms
Animals, Diabetes Mellitus, Type 2, Insulin Resistance, Lipids, Mice, Inbred C57BL, Obesity, Stilbenes, Weight Gain, Oxidative Stress, 3T3-L1 Cells, Adipogenesis, Mice, AMP-Activated Protein Kinases, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation. https://app.cochat.ai/papers/10.3390/nu15133006
The paper
Lam, C.-S., Xia, Y.-X., Chen, B.-S., Du, Y.-X., Liu, K.-L., & Zhang, H.-J. (2023). Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation. Nutrients. https://doi.org/10.3390/nu15133006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.